LB Group stock
002601.SZSHZLB Group Co., Ltd., Basic MaterialsISIN CNE1000015M3
46Score 46 out of 100, Weak
Price and trend
56 / 100
Price history
−22% in one yearThe chart shows daily closes over 15 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 12% below it.
Since May 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 57).
The price is 36% below its 52-week high. Largest decline in 15 years: 77% (August 2011 to July 2013).
Chart figures for advanced users
- SMA 50$2.26
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$2.55
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)57
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$2.09
- The lowest closing price of the last twelve months.
- Resistance$3.50
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- LB Group Co., Ltd. belongs to the Chemicals (Specialty) industry (China) and, with a market value of $5.33B, is number 61 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $3.9B (down 5.5% year on year) and earnings of $186.57M (down 42.6%).
- For fiscal 2026, analysts expect on average revenue of $4.44B (up 14.1%) and adjusted earnings per share of $0.10.
Show more
- MEQIRI Score 46 out of 100 (Weak): rank 357 of 467 in Basic Materials, median 58.
- The P/E is 37.3 (Chemicals (Specialty) median 20.2, own median of recent years 13.3).
- Our model puts fair value at $1.55, with the price 48% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 49.9% a year through 2027 (estimates from 3 analysts).
- Earnings turn into cashFree cash flow 208% of earnings over the last 12 months.Fundamentals 78
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 78
Weaknesses
- Margin fallingOperating margin 6.1%, average of the prior years 16.9% (to 2024).Profitability 29
- Above fair valuePrice 48% above the fair value of $1.55.Valuation 44
- Richly valuedP/E 37.3, Chemicals (Specialty) median 20.2, own median 13.3.Valuation 44
Its standout strength is fundamentals, while profitability and capital allocation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $1.19 and expensive above $2.21 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $1.89 (cash-flow model) and $1.21 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 9%. At 10% the fair value would be $1.43, at 8% it would be $1.72.
Valuation metrics
Half from the dividend model, half from earnings times the industry P/E (20.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 6.2% on the twelve months before. Revenue has grown strongly since 2008, at around 23% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 21%, operating 6%, net 5%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 23 Apr 2027in 162 days
- Last reported
- 30 Oct 2026EPS reported $0.03 (expected $0.03)in line with expectations
Analyst estimates
Earnings estimates have barely changed since 26 Oct 2026.
- Earnings per share
- $0.10+0.5%
- Revenue
- $4.44B0.0%
- Earnings per share
- $0.170.0%
- Revenue
- $4.93B0.0%
MEQIRI has stored the estimates since 26 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at LB Group
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 46
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Hubei Feilihua Quartz Glass300395.SZ $5.58B55
- BalchemBCPC $5.52B73
- Zhejiang Longsheng Group600352.SS $5.52B56
- Xinjiang Daqo New Energy688303.SS $5.47B32
- Sumitomo Chemical4005.T $5.32B53
- Navin Fluorine InternationalNAVINFLUOR.NS $5.29B79
- Kingfa Sci. & Tech.600143.SS $5.07B44
- Sensient TechnologiesSXT $5.06B59
ETFs that hold LB Group
Held by 31 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Xtrackers Harvest CSI A500 UCITS ETF 1DAH50 | 0.11% | 0.65% | €10.8M |
| HSBC MSCI China A UCITS ETF USDH41K | 0.11% | 0.30% | €68.25M |
| HSBC MSCI China UCITS ETFH4ZP | 0.02% | 0.28% | €865.21M |
Show 5 more
| Franklin FTSE China UCITS ETFFLXC | 0.02% | 0.19% | €1.3B |
| Amundi MSCI EM Asia ESG Broad Transition UCITS ETF AccLCUA | 0.02% | 0.25% | €628.34M |
| UBS MSCI China Universal UCITS ETF USD disUETC | 0.01% | 0.30% | €134.65M |
| iShares MSCI EM UCITS ETF USD (Dist)IQQE | 0.00% | 0.18% | €8.33B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.00% | 0.17% | €5.24B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = CN¥6.6707)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.